FDA neurological devices panel
This article was originally published in The Gray Sheet
Executive Summary
Meeting June 11 in Rockville, Maryland to "consider data pertaining to intracranial balloon embolization devices and make recommendations to the agency concerning the adequacy of this data as valid scientific evidence." For further information contact FDA's Robert Munzner at 301/427-1044.